Expression of urocortin III/stresscopin in human heart and kidney

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1897-1903

  Takahashi, Kazuhiro ^a   Totsune, Kazuhito ^b   Murakami, Osamu ^a   Saruta, Masayuki ^a   Nakabayashi, Masao ^a   Suzuki, Takashi ^a   Sasano, Hironobu ^a   Shibahara, Shigeki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN III;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; HEART; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; KIDNEY DISTAL TUBULE; KIDNEY TUBULE; MALE; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINE;

ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MIDDLE AGED; MYOCARDIUM; PITUITARY GLAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THALAMUS; TISSUE DISTRIBUTION;

EID: 1942472634     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031663     Document Type: Article

References (37)

1. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW 2001 Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575
2. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE 2001 Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848
3. Hsu SY, Hsueh AJ 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605-611
4. Li C, Vaughan J, Sawchenko PE, Vale WW 2002 Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22:991-1001
5. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS, Vale W 2003 Urocortin in is expressed in pancreatic β-cells and stimulates insulin and glucagon secretion. Endocrinology 144:3216-3224
6. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, De Souza EB 1996 Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77
7. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H 2002 Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 87:340-346
8. Okosi A, Brar BK, Chan M, D'Souza L, Smith E, Stephanou A, Latchman DS, Chowdrey HS, Knight RA 1998 Expression and protective effects of urocortin in cardiac myocytes. Neuropeptides 32:167-171
9. Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K 2000 Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol 279:H3031-H3039
10. Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H, Yoshimi T 1997 Urocortin expression in human pituitary gland and pituitary adenoma. J Clin Endocrinol Metab 82: 3842-3850
11. Takahashi K, Totsune K, Sone M, Ohneda M, Murakami O, Itoi K, Mouri T 1992 Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides 13:121-123
12. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Sasano H, Mouri T 1996 Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett 203:207-210
13. Totsune K, Sone M, Takahashi K, Ohneda M, Itoi K, Murakami O, Salto T, Mouri T, Yoshinaga K 1991 Immunoreactive endothelin in urine of patients with and without diabetes mellitus. J Cardiovasc Pharmacol 17(Suppl 7):S423-S424
14. Totsune K, Takahashi K, Satoh F, Sone M, Ohneda M, Satoh C, Murakami O, Mouri T 1996 Urinary immunoreactive brain natriuretic peptide in patients with renal disease. Regul Pept 63:141-147
15. Satoh C, Satoh F, Takahashi K, Murakami O, Sone M, Totsune K, Yabe T, Ohneda M, Fukuda M, Sugimura K, Ogawa S, Nagakubo H, Sato T, Mouri T 1999 Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy. Endocr J 46:139-146
16. Parkes DG, Vaughan J, Rivier J, Vale W, May CN 1997 Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 272:H2115-H2122
17. Parkes DG, Weisinger RS, May CN 2001 Cardiovascular actions of CRH and urocortin: an update. Peptides 22:821-827 (Review)
18. Terui K, Higashiyama A, Horiba N, Furukawa KI, Motomura S, Suda T 2001 Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 169:177-183
19. Sanz E, Fernandez N, Monge L, Climent B, Dieguez G, Garcia-Villalon AL 2003 Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females. Cardiovasc Res 58:706-711
20. Sanz E, Fernandez N, Monge L, Climent B, Dieguez G, Garcia-Villalon AL 2003 Relaxation of rat arteries by urocortin: effects of gender and diabetes. J Pharm Pharmacol 55:783-788
21. Brar BK, Stephanou A, Okosi A, Lawrence KM, Knight RA, Marber MS, Latchman DS 1999 CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Mol Cell Endocrinol 158:55-63
22. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS 2000 Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 275:8508-8514
23. Brar BK, Stephanou A, Knight R, Latchman DS 2002 Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 34:483-492
24. Lawrence KM, Chanalaris A, Scarabelli T, Hubank M, Pasini E, Townsend PA, Comini L, Ferrari R, Tinker A, Stephanou A, Knight RA, Latchman DS 2002 K(ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect. Circulation 106:1556-1562
25. Schulman D, Latchman DS, Yellon DM 2002 Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol 283:H1481-H1488
26. Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, Ferrari R, Knight R, Latchman DS 2002 Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol 40:155-161
27. Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O, Nakao K 1998 Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250:298-304
28. Chanalaris A, Lawrence KM, Stephanou A, Knight RD, Hsu SY, Hsueh AJ, Latchman DS 2003 Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes. J Mol Cell Cardiol 35:1295-1305
29. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjos OD, Latchman DS, Lee KF, Vale W 2004 Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145:24-35
30. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T 1993 Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
31. Eto T 2001 A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22:1693-1711 (Review)
32. Totsune K, Takahashi K, Mackenzie HS, Murakami O, Arihara Z, Sone M, Mouri T, Brenner BM, Ito S 2000 Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin Sci (Lond) 99:541-546
33. Takahashi K 2001 Adrenomedullin from a pheochromocytoma to the eye: implications of the adrenomedullin research for endocrinology in the 21st century. Tohoku J Exp Med 193:79-114 (Review)
34. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA 1999 Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401:282-286
35. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H, Murakami O 2001 Role of urotensin II in patients on dialysis. Lancet 358: 810-811
36. Baigent SM 2001 Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22:809-820 (Review)
37. Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T 1998 Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides 19:643-647